Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval 2024-07-31 18:33
JelloX Biotech collaborates with Mayo Clinic to develop AI enhanced 3D pathology imaging technology 2024-07-31 17:00
Fapon Delivers Customized IVD Solutions for the US Market at ADLM 2024 2024-07-31 14:42
Australian tech leading new digital biosecurity infrastructure 2024-07-31 11:32
FDA Grants Orphan Drug Designation (ODD) Status to Zymedi's ZMA001 for Pulmonary Arterial Hypertension 2024-07-31 08:00
Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics 2024-07-30 22:00
Connext Successfully Administers First Dose of CNT201 for Dupuytren's Contracture 2024-07-30 21:00
Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors 2024-07-30 14:00
Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia 2024-07-29 23:18
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™ 2024-07-29 22:30
Daewoong Pharmaceutical Receives Positive Recommendation from IDMC to Continue Developing its First-in-Class PRS Inhibitor, Bersiporocin 2024-07-29 20:00
Despite External Challenges, WuXi AppTec Maintained Stable Operations in First Half of 2024; Revenue and Profit of the Second Quarter Both Steadily Improved QoQ as Expected, with Revenue Up 16.0% QoQ and Adjusted Non-IFRS Net Profit Up 28.5% QoQ 2024-07-29 19:05
Akeso's sBLA for Ivonescimab in 1L Treatment of PD-L1 Positive NSCLC Accepted by NMPA 2024-07-29 17:26
Luye Pharma Announces U.S. FDA Approval of ERZOFRI® (paliperidone palmitate) Extended-Release Injectable Suspension for Treating Schizophrenia and Schizoaffective Disorder 2024-07-28 21:48
ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders 2024-07-26 21:00
MGI and HKBU Collaborate on Advanced Sequencing Technology to Combat Doping in Sports 2024-07-26 19:35
HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update 2024-07-26 19:00
Innovent and WeComput Announce Strategic Partnership to Advance AI-Driven Drug Discovery and Development 2024-07-26 09:33
Angel Yeast Showcases Innovative Yeast Protein Solutions at Growth Asia 2024 2024-07-26 01:20
Ractigen Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to RAG-18 for the treatment of Duchenne Muscular Dystrophy 2024-07-25 20:00
1 20 21 22 23 24 451